World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×
Spring Sale: Get 35% off with a min. purchase of 2 titles. Use code SPRING35. Valid till 31st Mar 2025.

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.
https://doi.org/10.1142/9789813236332_0023Cited by:0 (Source: Crossref)
Abstract:

Thymic malignancies represent a wide range of anatomical, clinical, histological, and molecular entities that may be aggressive and difficult to treat. The World Health Organization histopathologic classification distinguishes thymomas from thymic carcinomas; thymomas are further subdivided into different types (so-called A, AB, B1, B2, and B3) based upon the morphology of epithelial tumor cells (with an increasing degree of atypia from type A to B3), the relative proportion of the non-tumoral lymphocytic component (decreasing from type B1 to B3), and resemblance to normal thymic architecture. Thymic carcinomas are similar to their extrathymic counterpart, the most frequent subtype being squamous cell carcinoma.